Reyon Pharmaceutical corrects investor name in KRW 11 billion convertible bond issuance filing
Reyon Pharmaceutical issued a correction to its Oct. 8 filing on a planned 4th private convertible bond sale. The correction fixes an error in the named bond subscriber, changing it to “NH Hedge Multi Prime Private Investment Trust No. 1”. The planned issuance size remains KRW 11 billion. Disclaimer: This news brief wa